These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29191959)

  • 1. Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.
    Perico N; Casiraghi F; Remuzzi G
    J Am Soc Nephrol; 2018 Feb; 29(2):362-375. PubMed ID: 29191959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology.
    Hickson LJ; Herrmann SM; McNicholas BA; Griffin MD
    Kidney360; 2021 Mar; 2(3):542-557. PubMed ID: 34316720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
    Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
    Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.
    Yun CW; Lee SH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.
    Zhao L; Han F; Wang J; Chen J
    Stem Cell Res Ther; 2019 Dec; 10(1):385. PubMed ID: 31843011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.
    Aghajani Nargesi A; Lerman LO; Eirin A
    Stem Cell Res Ther; 2017 Dec; 8(1):273. PubMed ID: 29202871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells for tolerance induction in organ transplantation.
    Casiraghi F; Perico N; Remuzzi G
    Hum Immunol; 2018 May; 79(5):304-313. PubMed ID: 29288697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale of mesenchymal stem cell therapy in kidney injury.
    Fleig SV; Humphreys BD
    Nephron Clin Pract; 2014; 127(1-4):75-80. PubMed ID: 25343826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.
    Moghadasali R; Azarnia M; Hajinasrollah M; Arghani H; Nassiri SM; Molazem M; Vosough A; Mohitmafi S; Najarasl M; Ajdari Z; Yazdi RS; Bagheri M; Ghanaati H; Rafiei B; Gheisari Y; Baharvand H; Aghdami N
    Cytotherapy; 2014 Jun; 16(6):734-49. PubMed ID: 24801377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells in transplantation rejection and tolerance.
    English K; Wood KJ
    Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update nephrology 2013].
    Schmaderer C; Heemann U; Moog P
    MMW Fortschr Med; 2013 May; 155(9):56-9; quiz 60-1. PubMed ID: 23951664
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesenchymal Stem Cells in Kidney Repair.
    Morigi M; Rota C; Remuzzi G
    Methods Mol Biol; 2016; 1416():89-107. PubMed ID: 27236667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy for kidney injury: different options and mechanisms--mesenchymal and amniotic fluid stem cells.
    Morigi M; De Coppi P
    Nephron Exp Nephrol; 2014; 126(2):59. PubMed ID: 24854642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical translation of multipotent mesenchymal stromal cells in transplantation.
    Leuning DG; Reinders ME; de Fijter JW; Rabelink TJ
    Semin Nephrol; 2014 Jul; 34(4):351-64. PubMed ID: 25217264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade.
    Fazekas B; Griffin MD
    Kidney Int; 2020 Jun; 97(6):1130-1140. PubMed ID: 32305128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up.
    Makhlough A; Shekarchian S; Moghadasali R; Einollahi B; Dastgheib M; Janbabaee G; Hosseini SE; Falah N; Abbasi F; Baharvand H; Aghdami N
    Cytotherapy; 2018 May; 20(5):660-669. PubMed ID: 29580865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.
    Pileggi A; Xu X; Tan J; Ricordi C
    Curr Opin Organ Transplant; 2013 Dec; 18(6):672-81. PubMed ID: 24220050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients.
    Makhlough A; Shekarchian S; Moghadasali R; Einollahi B; Hosseini SE; Jaroughi N; Bolurieh T; Baharvand H; Aghdami N
    Stem Cell Res Ther; 2017 May; 8(1):116. PubMed ID: 28535817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.